EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses

2005 ◽  
Vol 19 (1-2) ◽  
pp. 218-228 ◽  
Author(s):  
Ralf A. Linker ◽  
Evelyn Rott ◽  
H.H. Hofstetter ◽  
T. Hanke ◽  
Klaus V. Toyka ◽  
...  
1996 ◽  
Vol 184 (4) ◽  
pp. 1295-1304 ◽  
Author(s):  
D R Brown ◽  
D J Fowell ◽  
D B Corry ◽  
T A Wynn ◽  
N H Moskowitz ◽  
...  

A number of investigations have established the critical role of interleukin 4 (IL-4) in mediating the development of T helper (Th)2 effector cells in vitro and in vivo. Despite intensive study, the origin of the IL-4 required for Th2 priming and differentiation remains unclear. Natural killer (NK)1.1+ alpha/beta T cell receptor+ T(NT) cells, a unique lineage of cells capable of producing large amounts of IL-4 after activation in vivo, are important candidates for directing Th2 priming. These cells are selected by the nonpolymorphic major histocompatibility complex (MHC) class I molecule, CD1, and are deficient in beta 2-microglobulin (beta 2m)-null mice. We used beta 2m-deficient mice on both BALB/c and C57BL/6 backgrounds to examine their capacity to mount Th2 immune responses after challenge with a number of well-characterized antigens administered by a variety of routes. As assessed by immunization with protein antigen, infection with Leishmania major, embolization with eggs of Schistosoma mansoni, intestinal infection with Nippostrongylus brasiliensis, or induction of airway hyperreactivity to aerosolized antigen, beta 2m-deficient mice developed functional type 2 immune responses that were not substantially different than those in wild-type mice. Production of IL-4 and the generation of immunoglobulin E (IgE) and eosinophil responses were preserved as assessed by a variety of assays. Collectively, these results present a comprehensive analysis of type 2 immune responses in beta 2m-deficient mice, and indicate that beta 2m-dependent NT cells are not required for Th2 development in vivo.


1993 ◽  
Vol 67 (1) ◽  
pp. 589-592 ◽  
Author(s):  
L Fiette ◽  
C Aubert ◽  
M Brahic ◽  
C P Rossi

Science ◽  
1992 ◽  
Vol 255 (5051) ◽  
pp. 1576-1578 ◽  
Author(s):  
D Muller ◽  
B. Koller ◽  
J. Whitton ◽  
K. LaPan ◽  
K. Brigman ◽  
...  

1992 ◽  
Vol 11 (1) ◽  
pp. 25-31 ◽  
Author(s):  
P. Pereira ◽  
M. Zijlstra ◽  
J. McMaster ◽  
J.M. Loring ◽  
R. Jaenisch ◽  
...  

1992 ◽  
Vol 89 (13) ◽  
pp. 6070-6074 ◽  
Author(s):  
M. K. Spriggs ◽  
B. H. Koller ◽  
T. Sato ◽  
P. J. Morrissey ◽  
W. C. Fanslow ◽  
...  

1992 ◽  
Vol 89 (2) ◽  
pp. 653-657 ◽  
Author(s):  
I. Correa ◽  
M. Bix ◽  
N. S. Liao ◽  
M. Zijlstra ◽  
R. Jaenisch ◽  
...  

1992 ◽  
Vol 175 (4) ◽  
pp. 885-893 ◽  
Author(s):  
M Zijlstra ◽  
H Auchincloss ◽  
J M Loring ◽  
C M Chase ◽  
P S Russell ◽  
...  

Mice homozygous for a beta 2-microglobulin (beta 2-m) gene disruption lack beta 2-m protein and are deficient for functional major histocompatibility complex class I (MHC-I) molecules. The mutant mice have normal numbers of CD4+8- T helper cells, but lack MHC-I-directed CD4-8+ cytotoxic T lymphocytes (CTLs). In this study we used the beta 2-m mutant mice to study the importance of MHC-I-directed immunity in skin graft rejection. Our results indicate that MHC-I-directed CD8+ CTLs are not essential in the rejection of allografts with whole MHC or multiple minor H differences. However, the absence of MHC-I-guided immunity profoundly reduces the ability of mutant mice to reject H-Y disparate grafts. In addition, we show that natural killer cells which vigorously reject MHC-I-deficient bone marrow grafts, are not effective in the destruction of MHC-I-deficient skin grafts.


Sign in / Sign up

Export Citation Format

Share Document